» Articles » PMID: 8490963

Physical Interaction of the Retinoblastoma Protein with Human D Cyclins

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1993 May 7
PMID 8490963
Citations 232
Authors
Affiliations
Soon will be listed here.
Abstract

The retinoblastoma protein (pRb) functions as a regulator of cell proliferation and in turn is regulated by cyclin-dependent kinases. Cyclins D1 and D3 can form complexes with pRb that resemble those formed by several viral oncoproteins and are disrupted by the adenovirus E1A oncoprotein and derived peptides. These cyclins contain a sequence motif similar to the pRb-binding conserved region II motif of the viral oncoproteins. Alteration of this motif in cyclin D1 prevents formation of cyclin D1-pRb complexes while enhancing the biological activity of cyclin D1 assayed in vivo. We conclude that cyclins D1 and D3 interact with pRb in a fashion distinct from cyclins A and E, which can induce pRb hyperphosphorylation, and that cyclin D1 activity may be regulated by its association with pRb.

Citing Articles

Regulation of cell cycle in plant gametes: when is the right time to divide?.

Simonini S Development. 2025; 152(2).

PMID: 39831611 PMC: 11829769. DOI: 10.1242/dev.204217.


CCND2 Modified mRNA Activates Cell Cycle of Cardiomyocytes in Hearts With Myocardial Infarction in Mice and Pigs.

Sun J, Wang L, Matthews R, Walcott G, Lu Y, Wei Y Circ Res. 2023; 133(6):484-504.

PMID: 37565345 PMC: 10529295. DOI: 10.1161/CIRCRESAHA.123.322929.


CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferation.

Quandt E, Masip N, Hernandez-Ortega S, Sanchez-Botet A, Gasa L, Fernandez-Elorduy A Mol Oncol. 2023; 17(7):1228-1245.

PMID: 37081792 PMC: 10323892. DOI: 10.1002/1878-0261.13438.


Unraveling the links between neurodegeneration and Epstein-Barr virus-mediated cell cycle dysregulation.

Tiwari D, Mittal N, Jha H Curr Res Neurobiol. 2023; 3:100046.

PMID: 36685766 PMC: 9846474. DOI: 10.1016/j.crneur.2022.100046.


Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma.

Ng Y, Ramberger E, Bohl S, Dolnik A, Steinebach C, Conrad T Nat Commun. 2022; 13(1):1009.

PMID: 35197447 PMC: 8866544. DOI: 10.1038/s41467-022-28515-1.